Walleye Capital LLC Spring Works Therapeutics, Inc. Transaction History
Walleye Capital LLC
- $46.2 Billion
- Q3 2024
A detailed history of Walleye Capital LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 286,093 shares of SWTX stock, worth $11.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
286,093
Previous 12,900
2117.78%
Holding current value
$11.7 Million
Previous $485,000
1789.9%
% of portfolio
0.02%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SWTX
# of Institutions
239Shares Held
70MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$275 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$230 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$158 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$144 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$140 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.56B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...